HYTN Innovations Inc. announced that its wholly owned subsidiary, HYTN Cannabis Inc., has been awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers. National sales of HYTN's cannabis-infused sparkling beverages had already begun through a partnership agreement with Emerald Health Therapeutics Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 CAD | -5.26% | +26.32% | +414.29% |
03-26 | HYTN Innovations Inc. announced that it has received CAD 0.74855 million in funding | CI |
02-29 | HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+414.29% | 21.45M | |
+4.86% | 266B | |
+1.55% | 45.63B | |
+16.32% | 22.29B | |
+47.07% | 18.6B | |
-12.57% | 16.17B | |
+14.53% | 12.69B | |
+2.04% | 11.23B | |
+23.16% | 11.15B | |
+6.92% | 9.23B |
- Stock Market
- Equities
- HYTN Stock
- News HYTN Innovations Inc.
- HYTN Innovations Inc. Announces its Wholly Owned Subsidiary, HYTN Cannabis Inc. Receives Approval for the Sale of Cannabis to Provincially and Territorially Authorized Retailers